Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

QTRX Quanterix Corporation

15,97

-0,35 (-2,14%)

01 Jun 2024 - Geschlossen

Verzögert um 15 Minuten

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Article too big to display. Click here to view on the SEC website

Quanterix (NASDAQ:QTRX)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Click Here for more Quanterix Charts.

Quanterix (NASDAQ:QTRX)
Historical Stock Chart
Von Jun 2023 bis Jun 2024

Click Here for more Quanterix Charts.

News Quanterix Corporation

Form SD - Specialized disclosure report
Freitag 31 Mai 2024 (19 Stunden vor) • Edgar (US Regulatory)

Quanterix to Present at Leerink Partners Healthcare Crossroads Conference 2024
Mittwoch 22 Mai 2024 (1 Woche vor) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 16 Mai 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 14 Mai 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mittwoch 8 Mai 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 7 Mai 2024 (4 Wochen vor) • Edgar (US Regulatory)

Quanterix Releases Financial Results for the First Quarter of 2024
Dienstag 7 Mai 2024 (4 Wochen vor) • Business Wire

Quanterix To Report First Quarter 2024 Financial Results
Montag 29 April 2024 (1 Monat vor) • Business Wire

Quanterix Outlines Partner Path With Labs to Expedite Building Global Alzheimer’s Disease Testing Infrastructure
Donnerstag 21 März 2024 (2 Monate vor) • Business Wire

Form S-8 - Securities to be offered to employees in employee benefit plans
Montag 4 März 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 4 März 2024 (3 Monate vor) • Edgar (US Regulatory)

Quanterix Granted Breakthrough Device Designation from U.S. FDA for Blood-Based p-Tau 217 Test for Alzheimer’s Disease
Montag 4 März 2024 (3 Monate vor) • Business Wire

Weitere Quanterix Corporation News-Artikel

Blackrock Throgmorton

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen